Home General Biotechnology Drug Patent Expirations in January 2009

Drug Patent Expirations in January 2009

Courtesy of DrugPatentWatch.com:

Drug Patent Expirations in January 2009

*Drugs may be covered by multiple patents

TradenameApplicantGeneric NamePatent NumberPatent Expiration
COVERA-HSGd Searle Llcverapamil hydrochloride5,082,668Jan 21, 2009
GLYSETPharmacia And Upjohnmiglitol4,639,436Jan 27, 2009
KEPPRAUcb Inclevetiracetam4,943,639Jan 14, 2009
KEPPRA XRUcb Inclevetiracetam4,943,639Jan 14, 2009
LAMICTALGlaxosmithklinelamotrigine4,602,017Jan 22, 2009
LAMICTAL CDGlaxosmithklinelamotrigine4,602,017Jan 22, 2009
MYLOTARGWyeth Pharms Incgemtuzumab ozogamicin5,079,233Jan 7, 2009
PRAVACHOLBristol Myers Squibbpravastatin sodium5,030,447Jan 9, 2009
PRAVACHOLBristol Myers Squibbpravastatin sodium5,180,589Jan 9, 2009
PRAVIGARD PAC (COPACKAGED)Bristol Myers Squibbaspirin; pravastatin sodium5,030,447Jan 9, 2009
PRAVIGARD PAC (COPACKAGED)Bristol Myers Squibbaspirin; pravastatin sodium5,180,589Jan 9, 2009
TRICORAbbottfenofibrate4,895,726Jan 19, 2009
TRICOR (MICRONIZED)Abbottfenofibrate4,895,726Jan 19, 2009
XIBROMIsta Pharmsbromfenac sodium4,910,225Jan 24, 2009
ZOLOFTPfizersertraline hydrochloride5,744,501Jan 6, 2009
ZOLOFTPfizersertraline hydrochloride5,789,449Jan 6, 2009

Courtesy of DrugPatentWatch.com

Want to receive this information by email? Subscribe to the DrugPatentWatch Patent Expiration Bulletin.

NO COMMENTS

Leave a Reply